Sanofi Pasteur builds major manufacturing facility for vaccines

10/5/2011 | Business Standard (India)

Sanofi's vaccine division, Sanofi Pasteur, is building a state-of-the-art plant in India as part of a 2015 goal to achieve 40% of sales from emerging markets. The facility, touted as the largest in Asia, will be fully operational in October 2012. Sanofi invested $300 million for capacity expansion after buying India's Shantha Biotechnics in 2009, said CEO Chris Viehbacher.

View Full Article in:

Business Standard (India)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA